• 1
    Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res. 1996; 19: 117.
  • 2
    Stadtman ER. Protein oxidation and aging. Science 1992; 257: 12201224.
  • 3
    Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan E, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels of patients with schizophrenia and bipolar disorder. Cell Biochem. Funct. 2002; 20: 171175.
  • 4
    Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001; 64: 4351.
  • 5
    Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 2002; 46: 2732.
  • 6
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Antioxidant enzyme and malondialdehyde levels in patients with social phobia. Psychiatry Res. (in press).
  • 7
    Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol. Bull. 1995; 31: 159165.
  • 8
    Zhang XY, Zhou DF, Su JM, Zhang PY. The effect of extract of gingko biloba added to haloperidol on superoxide dismutase in patients with schizophrenia. J. Clin. Psychopharmacol. 2001; 21: 8588.
  • 9
    Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Department of Psychiatry College of Medicine, The University of Iowa, Iowa City, 1983.
  • 10
    Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988; 34: 497500.
  • 11
    Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte gluthathione peroxidase. J. Lab. Clin. Med. 1967; 70: 158168.
  • 12
    Aebi H. Catalase. In: BergmeyerHU (ed.). Methods of Enzymatic Analysis. Academic Press, New York, 1974; 673677.
  • 13
    Yao JK, Reddy R, McElhinny LG, Van Kammen DP, 1998. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr. Res. 1998; 32: 18.
  • 14
    Yao JK, Reddy R, Van Kammen DP. Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res. 1998; 80: 2939.
  • 15
    Lohr JB. Oxygen radicals and neuropsychiatric illness: some speculations. Arch. Gen. Psychiatry 1991; 48: 10971106.
  • 16
    Herken H, Uz E, Özyurt H, Soðüt S, Virit O, Akyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry 2001; 6: 6673.
  • 17
    Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin. Chem. Lab. Med. 2000; 38: 12771281.
  • 18
    Graham DG. On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 1979; 103: 359362.
  • 19
    Van der Vliet A, Bast A. Effect of oxidative stress on receptors and signal transmission. Chem. Biol. Interact 1992; 85: 95116.
  • 20
    Kleijnen J, Knipschild P. Gingko biloba for cerebral insufficiency. Br. J. Clin. Pharmacol. 1992; 34: 352358.